NBI components
The NASDAQ Biotechnology constituents can be found in the table below. Sort NBI stock components by various financial metrics and data such as performance, dividends, income statement and balance sheet.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AZNAstraZeneca PLCDR | 210.441 B USD | 68.55 USD | +0.28% | 4.72 M | 0.81 | 35.92 | 1.91 USD | +80.90% | 2.08% | Health Technology | Buy |
 AMGNAmgen Inc. | 144.125 B USD | 268.93 USD | +2.35% | 3.375 M | 1.67 | 21.54 | 12.48 USD | +3.07% | 3.29% | Health Technology | Buy |
 SNYSanofiDR | 113.98 B USD | 46.30 USD | +2.00% | 3.254 M | 1.39 | 19.93 | 2.32 USD | −20.45% | 3.03% | Health Technology | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 101.846 B USD | 394.28 USD | +0.20% | 1.324 M | 1.41 | 28.38 | 13.89 USD | +8.36% | 0.00% | Health Technology | Buy |
 REGNRegeneron Pharmaceuticals, Inc. | 98.437 B USD | 896.82 USD | +0.32% | 501.688 K | 1.03 | 25.81 | 34.75 USD | −9.14% | 0.00% | Health Technology | Buy |
 GILDGilead Sciences, Inc. | 83.248 B USD | 66.76 USD | +0.91% | 10.656 M | 1.74 | 14.82 | 4.50 USD | +23.76% | 4.56% | Health Technology | Buy |
 MRNAModerna, Inc. | 38.828 B USD | 101.41 USD | −0.58% | 2.608 M | 0.85 | — | −12.41 USD | −162.10% | 0.00% | Health Technology | Buy |
 BIIBBiogen Inc. | 28.255 B USD | 194.38 USD | +2.03% | 1.6 M | 1.50 | 24.36 | 7.98 USD | −61.85% | 0.00% | Health Technology | Buy |
 ARGXargenx SEDR | 21.632 B USD | 360.23 USD | +0.51% | 329.071 K | 1.70 | — | −5.17 USD | +34.20% | 0.00% | Health Technology | Strong buy |
 BNTXBioNTech SEDR | 20.485 B USD | 86.81 USD | +0.74% | 1.577 M | 2.36 | 21.17 | 4.10 USD | −89.57% | 0.00% | Health Technology | Buy |
 GMABGenmab A/SDR | 18.683 B USD | 28.70 USD | +1.31% | 361.028 K | 1.05 | 29.84 | 0.96 USD | −17.61% | 0.00% | Health Technology | Buy |
 ILMNIllumina, Inc. | 18.66 B USD | 117.43 USD | +0.63% | 1.399 M | 0.90 | — | −7.34 USD | +73.84% | 0.00% | Health Technology | Buy |
 ALNYAlnylam Pharmaceuticals, Inc. | 18.261 B USD | 144.41 USD | −0.52% | 702.519 K | 1.40 | — | −3.56 USD | +61.68% | 0.00% | Health Technology | Buy |
 RPRXRoyalty Pharma plc | 16.824 B USD | 28.16 USD | +0.97% | 1.776 M | 0.67 | 11.11 | 2.54 USD | +2145.70% | 2.90% | Health Technology | Strong buy |
 BMRNBioMarin Pharmaceutical Inc. | 16.82 B USD | 88.63 USD | −1.60% | 1.779 M | 1.13 | 101.73 | 0.87 USD | +19.31% | 0.00% | Health Technology | Buy |
 BGNEBeiGene, Ltd.DR | 14.448 B USD | 129.52 USD | −1.85% | 296.406 K | 1.62 | — | −8.50 USD | +56.33% | 0.00% | Health Technology | Strong buy |
 VTRSViatris Inc. | 13.36 B USD | 11.25 USD | +1.17% | 4.68 M | 0.78 | 265.33 | 0.04 USD | −97.51% | 4.32% | Health Technology | Neutral |
 NBIXNeurocrine Biosciences, Inc. | 13.135 B USD | 132.00 USD | −0.41% | 556.052 K | 0.84 | 54.32 | 2.43 USD | +57.74% | 0.00% | Health Technology | Buy |
 INCYIncyte Corporation | 11.754 B USD | 52.35 USD | −0.89% | 2.181 M | 1.40 | 19.79 | 2.64 USD | +73.79% | 0.00% | Health Technology | Buy |
 MEDPMedpace Holdings, Inc. | 11.442 B USD | 372.00 USD | −0.62% | 221.633 K | 1.14 | 41.91 | 8.88 USD | +21.41% | 0.00% | Commercial Services | Buy |
 UTHRUnited Therapeutics Corporation | 11.197 B USD | 237.93 USD | +0.42% | 395.447 K | 0.89 | 11.99 | 19.84 USD | +31.99% | 0.00% | Health Technology | Buy |
 SRPTSarepta Therapeutics, Inc. | 10.852 B USD | 115.62 USD | −0.80% | 641.082 K | 1.18 | — | −6.16 USD | +23.35% | 0.00% | Health Technology | Strong buy |
 LEGNLegend Biotech CorporationDR | 8.572 B USD | 46.19 USD | −1.97% | 1.236 M | 1.11 | — | −2.95 USD | −7.91% | 0.00% | Health Technology | Strong buy |
 ROIVRoivant Sciences Ltd. | 8.429 B USD | 10.46 USD | +0.97% | 4.663 M | 0.96 | 2.01 | 5.21 USD | — | 0.00% | Health Technology | Strong buy |
 ASNDAscendis Pharma A/SDR | 7.976 B USD | 140.17 USD | −0.51% | 270.427 K | 0.82 | — | −9.26 USD | +14.73% | 0.00% | Health Technology | Strong buy |
 CYTKCytokinetics, Incorporated | 7.064 B USD | 67.55 USD | +0.82% | 1.502 M | 1.44 | — | −5.45 USD | −28.21% | 0.00% | Health Technology | Strong buy |
 ITCIIntra-Cellular Therapies Inc. | 7.054 B USD | 72.37 USD | +0.51% | 2.189 M | 1.18 | — | −1.46 USD | +46.55% | 0.00% | Health Technology | Strong buy |
 JAZZJazz Pharmaceuticals plc | 6.854 B USD | 109.94 USD | +0.61% | 756.569 K | 1.32 | 19.05 | 5.77 USD | — | 0.00% | Health Technology | Buy |
 EXELExelixis, Inc. | 6.828 B USD | 22.52 USD | +0.13% | 2.33 M | 1.19 | 34.80 | 0.65 USD | +15.26% | 0.00% | Health Technology | Buy |
 PCVXVaxcyte, Inc. | 6.616 B USD | 60.83 USD | +0.35% | 1.325 M | 2.14 | — | −4.21 USD | −22.36% | 0.00% | Health Technology | Strong buy |
 IONSIonis Pharmaceuticals, Inc. | 5.929 B USD | 40.68 USD | −0.32% | 845.986 K | 0.95 | — | −2.56 USD | −34.71% | 0.00% | Health Technology | Buy |
 RVMDRevolution Medicines, Inc. | 5.751 B USD | 34.92 USD | −2.54% | 1.244 M | 0.75 | — | −3.77 USD | −21.72% | 0.00% | Health Technology | Strong buy |
 APLSApellis Pharmaceuticals, Inc. | 5.731 B USD | 47.53 USD | +0.04% | 1.175 M | 0.87 | — | −4.48 USD | +26.94% | 0.00% | Health Technology | Strong buy |
 GRFSGrifols, S.A.DR | 5.55 B USD | 6.28 USD | −3.98% | 1.237 M | 0.93 | 25.04 | 0.25 USD | −74.09% | 0.00% | Health Technology | Buy |
 BPMCBlueprint Medicines Corporation | 5.318 B USD | 86.85 USD | −2.31% | 799.678 K | 1.46 | — | −8.37 USD | +10.38% | 0.00% | Health Technology | Buy |
 HALOHalozyme Therapeutics, Inc. | 4.909 B USD | 38.64 USD | +2.20% | 1.259 M | 1.31 | 18.32 | 2.11 USD | +46.10% | 0.00% | Health Technology | Strong buy |
 CRSPCRISPR Therapeutics AG | 4.673 B USD | 55.05 USD | −1.98% | 1.762 M | 1.29 | — | −1.97 USD | +76.45% | 0.00% | Health Technology | Buy |
 BBIOBridgeBio Pharma, Inc. | 4.563 B USD | 24.74 USD | −0.84% | 2.027 M | 1.33 | — | −3.95 USD | −21.03% | 0.00% | Health Technology | Strong buy |
 KRYSKrystal Biotech, Inc. | 4.485 B USD | 158.53 USD | −3.32% | 341.399 K | 1.40 | 1783.24 | 0.09 USD | — | 0.00% | Health Technology | Strong buy |
 MDGLMadrigal Pharmaceuticals, Inc. | 4.451 B USD | 212.04 USD | −4.60% | 624.609 K | 2.33 | — | −19.94 USD | −15.71% | 0.00% | Health Technology | Strong buy |
 ALPNAlpine Immune Sciences, Inc. | 4.231 B USD | 64.55 USD | +0.19% | 3.979 M | 0.59 | — | −0.69 USD | +58.73% | 0.00% | Health Technology | Neutral |
 IMVTImmunovant, Inc. | 4.1 B USD | 28.22 USD | −0.35% | 1.079 M | 0.98 | — | −1.83 USD | −10.48% | 0.00% | Health Technology | Strong buy |
 ALKSAlkermes plc | 4.035 B USD | 23.85 USD | +0.38% | 2.415 M | 1.12 | 11.53 | 2.07 USD | — | 0.00% | Health Technology | Buy |
 NUVLNuvalent, Inc. | 4.021 B USD | 62.76 USD | −0.48% | 1.246 M | 1.66 | — | −2.16 USD | −31.75% | 0.00% | Health Technology | Strong buy |
 INSMInsmed Incorporated | 3.611 B USD | 24.32 USD | −1.94% | 5.534 M | 3.42 | — | −5.35 USD | −37.57% | 0.00% | Health Technology | Strong buy |
 IBRXImmunityBio, Inc. | 3.552 B USD | 5.27 USD | +7.33% | 4.557 M | 1.15 | — | −1.13 USD | −8.15% | 0.00% | Health Technology | Neutral |
 RAREUltragenyx Pharmaceutical Inc. | 3.489 B USD | 42.37 USD | −2.33% | 675.366 K | 0.82 | — | −8.33 USD | +17.65% | 0.00% | Health Technology | Strong buy |
 CRNXCrinetics Pharmaceuticals, Inc. | 3.349 B USD | 42.97 USD | −0.09% | 624.762 K | 0.99 | — | −3.70 USD | −17.50% | 0.00% | Health Technology | Strong buy |
 AXSMAxsome Therapeutics, Inc. | 3.217 B USD | 67.90 USD | +3.32% | 890.721 K | 1.64 | — | −5.20 USD | −13.57% | 0.00% | Health Technology | Strong buy |
 FTREFortrea Holdings Inc. | 3.174 B USD | 35.50 USD | −1.39% | 1.083 M | 1.43 | — | −0.04 USD | — | 0.00% | Commercial Services | Buy |
 IOVAIovance Biotherapeutics, Inc. | 3.159 B USD | 11.31 USD | −3.50% | 5.262 M | 1.17 | — | −1.89 USD | +23.77% | 0.00% | Health Technology | Strong buy |
 FOLDAmicus Therapeutics, Inc. | 3.134 B USD | 10.61 USD | +2.71% | 2.502 M | 1.09 | — | −0.52 USD | +37.05% | 0.00% | Health Technology | Buy |
 XENEXenon Pharmaceuticals Inc. | 3.008 B USD | 39.88 USD | −1.07% | 362.875 K | 1.16 | — | −2.73 USD | −33.48% | 0.00% | Health Technology | Strong buy |
 SWTXSpringWorks Therapeutics, Inc. | 2.959 B USD | 40.10 USD | −5.58% | 1.414 M | 2.18 | — | −4.98 USD | +4.73% | 0.00% | Health Technology | Strong buy |
 HCMHUTCHMED (China) LimitedDR | 2.903 B USD | 16.50 USD | +0.86% | 61.047 K | 0.42 | 28.71 | 0.57 USD | — | 0.00% | Health Technology | Strong buy |
 ACADACADIA Pharmaceuticals Inc. | 2.771 B USD | 16.82 USD | −1.46% | 3.522 M | 2.77 | — | −0.38 USD | +71.57% | 0.00% | Health Technology | Buy |
 IDYAIDEAYA Biosciences, Inc. | 2.768 B USD | 37.13 USD | −1.30% | 726.14 K | 1.45 | — | −1.96 USD | −40.50% | 0.00% | Health Technology | Strong buy |
 ARWRArrowhead Pharmaceuticals, Inc. | 2.767 B USD | 22.33 USD | −1.24% | 964.283 K | 1.09 | — | −2.77 USD | −88.90% | 0.00% | Health Technology | Buy |
 ACLXArcellx, Inc. | 2.752 B USD | 51.65 USD | −5.23% | 741.258 K | 1.53 | — | −1.51 USD | +65.88% | 0.00% | Health Technology | Strong buy |
 IMCRImmunocore Holdings plcDR | 2.722 B USD | 55.68 USD | +1.72% | 447.723 K | 0.91 | — | −1.14 USD | 0.00% | 0.00% | Health Technology | Strong buy |
 APGEApogee Therapeutics, Inc. | 2.694 B USD | 46.91 USD | −2.98% | 473.722 K | 1.10 | — | — | — | 0.00% | Health Technology | Strong buy |
 JANXJanux Therapeutics, Inc. | 2.515 B USD | 48.69 USD | −0.33% | 668.771 K | 0.59 | — | −1.34 USD | +11.77% | 0.00% | Health Technology | Strong buy |
 SMMTSummit Therapeutics Inc. | 2.456 B USD | 3.50 USD | −0.28% | 1.727 M | 1.05 | — | −1.54 USD | −147.47% | 0.00% | Health Technology | Strong buy |
 ARVNArvinas, Inc. | 2.372 B USD | 34.72 USD | +1.25% | 944.326 K | 1.59 | — | −6.50 USD | −22.31% | 0.00% | Health Technology | Strong buy |
 MRUSMerus N.V. | 2.304 B USD | 39.81 USD | −1.63% | 795.015 K | 1.68 | — | −2.99 USD | −4.12% | 0.00% | Health Technology | Strong buy |
 RYTMRhythm Pharmaceuticals, Inc. | 2.286 B USD | 38.01 USD | −0.26% | 615.931 K | 1.21 | — | −3.21 USD | +8.13% | 0.00% | Health Technology | Strong buy |
 DNLIDenali Therapeutics Inc. | 2.227 B USD | 16.00 USD | −3.61% | 1.48 M | 1.43 | — | −1.09 USD | +57.94% | 0.00% | Health Technology | Strong buy |
 GERNGeron Corporation | 2.17 B USD | 3.69 USD | −1.07% | 8.225 M | 0.70 | — | −0.32 USD | +11.31% | 0.00% | Health Technology | Strong buy |
 VCELVericel Corporation | 2.116 B USD | 43.74 USD | −0.27% | 522.006 K | 1.67 | — | −0.08 USD | +76.87% | 0.00% | Health Technology | Strong buy |
 KROSKeros Therapeutics, Inc. | 2.097 B USD | 58.28 USD | −1.14% | 348.567 K | 1.38 | — | −5.19 USD | −25.19% | 0.00% | Health Technology | Strong buy |
 VERAVera Therapeutics, Inc. | 2.087 B USD | 38.00 USD | −3.75% | 1.376 M | 0.85 | — | −2.28 USD | +31.36% | 0.00% | Health Technology | Strong buy |
 NTLAIntellia Therapeutics, Inc. | 2.08 B USD | 21.57 USD | +1.17% | 1.392 M | 1.14 | — | −5.42 USD | +12.31% | 0.00% | Health Technology | Buy |
 KYMRKymera Therapeutics, Inc. | 2.076 B USD | 33.97 USD | −3.27% | 627.447 K | 1.25 | — | −2.52 USD | +12.49% | 0.00% | Health Technology | Buy |
 RCKTRocket Pharmaceuticals, Inc. | 2.063 B USD | 22.80 USD | −2.90% | 960.815 K | 1.47 | — | −2.94 USD | +10.53% | 0.00% | Health Technology | Strong buy |
 GHGuardant Health, Inc. | 1.956 B USD | 16.07 USD | −3.60% | 1.855 M | 0.98 | — | −4.28 USD | +33.21% | 0.00% | Health Services | Strong buy |
 AMPHAmphastar Pharmaceuticals, Inc. | 1.955 B USD | 40.01 USD | +3.52% | 410.091 K | 1.14 | 15.46 | 2.59 USD | +47.97% | 0.00% | Health Technology | Buy |
 BEAMBeam Therapeutics Inc. | 1.952 B USD | 23.90 USD | −1.69% | 4.505 M | 2.84 | — | −1.91 USD | +53.81% | 0.00% | Health Technology | Buy |
 PTCTPTC Therapeutics, Inc. | 1.94 B USD | 25.32 USD | +2.55% | 3.932 M | 6.05 | — | −8.37 USD | −7.52% | 0.00% | Health Technology | Neutral |
 DYNDyne Therapeutics, Inc. | 1.935 B USD | 23.86 USD | +0.89% | 973.255 K | 1.19 | — | −3.94 USD | −21.58% | 0.00% | Health Technology | Strong buy |
 GLPGGalapagos NVDR | 1.92 B USD | 29.08 USD | +0.59% | 86.958 K | 0.48 | — | −2.32 USD | −3035.40% | 0.00% | Health Technology | Neutral |
 MRVIMaravai LifeSciences Holdings, Inc. | 1.835 B USD | 7.30 USD | −4.07% | 1.329 M | 0.74 | — | −0.90 USD | −154.48% | 0.00% | Health Technology | Buy |
 RNAAvidity Biosciences, Inc. | 1.812 B USD | 22.73 USD | −1.35% | 1.009 M | 1.26 | — | −2.90 USD | +12.72% | 0.00% | Health Technology | Strong buy |
 FUSNFusion Pharmaceuticals Inc. | 1.804 B USD | 21.26 USD | +0.05% | 442.369 K | 0.32 | — | −1.47 USD | +26.68% | 0.00% | Health Technology | Neutral |
 SNDXSyndax Pharmaceuticals, Inc. | 1.767 B USD | 20.80 USD | +1.51% | 853.555 K | 0.97 | — | −2.96 USD | −20.58% | 0.00% | Health Technology | Strong buy |
 GPCRStructure Therapeutics Inc.DR | 1.686 B USD | 36.36 USD | +0.50% | 383.323 K | 0.81 | — | −2.51 USD | — | 0.00% | Commercial Services | Strong buy |
 SANASana Biotechnology, Inc. | 1.678 B USD | 7.61 USD | −1.55% | 3.379 M | 2.71 | — | −1.46 USD | −2.51% | 0.00% | Health Technology | Strong buy |
 HRMYHarmony Biosciences Holdings, Inc. | 1.669 B USD | 29.40 USD | +1.27% | 385.764 K | 0.89 | 13.79 | 2.13 USD | −28.09% | 0.00% | Health Technology | Buy |
| AAVDLAvadel Pharmaceuticals plc DR | 1.664 B USD | 17.33 USD | −0.29% | 1.333 M | 1.12 | — | −2.02 USD | +11.68% | 0.00% | Health Technology | Strong buy |
 MYGNMyriad Genetics, Inc. | 1.663 B USD | 18.50 USD | −0.05% | 487.827 K | 0.90 | — | −3.20 USD | −131.34% | 0.00% | Health Technology | Neutral |
 AGIOAgios Pharmaceuticals, Inc. | 1.659 B USD | 29.53 USD | +0.34% | 747.431 K | 1.12 | — | −6.33 USD | −49.22% | 0.00% | Health Technology | Buy |
 INBXInhibrx, Inc. | 1.627 B USD | 34.32 USD | −0.38% | 216.39 K | 0.46 | — | −5.03 USD | −39.09% | 0.00% | Health Technology | Neutral |
 TWSTTwist Bioscience Corporation | 1.616 B USD | 27.95 USD | −1.45% | 1.09 M | 1.45 | — | −3.60 USD | +6.63% | 0.00% | Health Technology | Buy |
 SUPNSupernus Pharmaceuticals, Inc. | 1.609 B USD | 29.40 USD | +1.84% | 361.633 K | 0.91 | — | −0.00 USD | −100.09% | 0.00% | Health Technology | Buy |
 RXRXRecursion Pharmaceuticals, Inc. | 1.586 B USD | 7.35 USD | −0.68% | 3.945 M | 1.13 | — | −1.55 USD | −13.81% | 0.00% | Health Technology | Buy |
 DVAXDynavax Technologies Corporation | 1.541 B USD | 11.80 USD | +4.06% | 9.289 M | 5.44 | — | −0.07 USD | −103.52% | 0.00% | Health Technology | Strong buy |
 ARDXArdelyx, Inc. | 1.508 B USD | 6.48 USD | +0.62% | 5.634 M | 1.13 | — | −0.30 USD | +37.08% | 0.00% | Health Technology | Strong buy |
 PTGXProtagonist Therapeutics, Inc. | 1.492 B USD | 25.61 USD | +1.55% | 452.229 K | 0.84 | — | −1.48 USD | +43.06% | 0.00% | Health Technology | Strong buy |
 VCYTVeracyte, Inc. | 1.46 B USD | 19.45 USD | +1.30% | 1.36 M | 2.21 | — | −1.02 USD | −99.73% | 0.00% | Health Technology | Buy |
 ADMAADMA Biologics Inc | 1.453 B USD | 6.27 USD | +1.13% | 3.244 M | 1.60 | — | −0.13 USD | +62.17% | 0.00% | Health Technology | Strong buy |
 AKROAkero Therapeutics, Inc. | 1.436 B USD | 20.76 USD | +1.22% | 789.143 K | 1.14 | — | −2.85 USD | +2.64% | 0.00% | Health Technology | Strong buy |